DocChart
Population Health
Patient panel
Loading the selected patient panel and chart summaries.
Switching panel
Preparing patient rows, flags, problems, medications, and last visit summaries.
Panel size
...
Loading patient records
With open flags
...
Loading review signals
With recent visit
...
Loading visit dates
Accepted chart labels
Human-confirmed labels that stay on the chart after a cohort membership is accepted.
0, active
No accepted chart labels yet. Cohort memberships and review tasks still appear below before anything is accepted.
Cohort memberships
Patient-list membership from saved cohort runs. These are source lists, not task status or accepted chart labels.
1, current
Smoking / Lung Screening review cohort
Chart evidence: Care element: smoking_status never smoker form
membership needs review
No review task has been created from this cohort for this patient yet.
Open review tasks
3
New, in review, or accepted tasks
Last visit
2025-01-17
Appointment or derived chart contact
Latest A1c
8.3 %
2026-04-22
Latest BP
134 mmHg / 70 mmHg
2025-06-09
Extracted signals
0
Optional text signals
Chart volume
47
3 notes, 4 reports
A compact view of what needs attention before opening the full imported record.
Review priority
2
active signal
s
3
0
0
Review these before relying on the imported record clinically.
Review needed
3 open flags
Open clinical review items need status, assignment, or closure.
A1c above review threshold
Latest HbA1c is 8.3 % on 2026-04-22.
Active problems
4
Glaucoma suspect
active
Prostate cancer survivor
active
Chronic kidney disease stage 3a
N18
active
Type 2 diabetes mellitus
E11
active
Active medications
2
Metformin
500 mg BID
Empagliflozin
10 mg daily
AI-CDS actions selected from Flags & Tasks. These stay visible on the chart for follow-up.
0, selected
No selected follow-up actions
Select AI-CDS actions from Flags & Tasks to keep them visible on this chart.
Saved population-health queue work for this patient: calls, recalls, flags, snoozes, exclusions, and completions.
Optional text-derived evidence extracted beside the imported chart. Each signal stays traceable to source text.
No extracted signals for this patient
Reprocess an import with text enrichment to attach suggested evidence to this patient record.
Most recent values are summarized here so the timeline can stay readable.
Recent chart, workflow, AI, cohort, and audit events shown in the user's local time.
33, more source rows below
Latest narrative evidence, clipped for scanning.
Recent report headers and excerpts.
Audit view for imported records. Kept collapsed so the working chart remains usable.
PHM saved action
PHM action: SURVIVORSHIP_PLAN_DUE
status=outreach_done | imported | next review=2026-06-16 | Review evidence for Survivorship plan review due; confirm appropriateness before contacting patient.
PHM saved action
PHM action: CKD_LOW_EGFR_REVIEW
status=outreach_planned | imported | next review=2026-06-09 | Review evidence for Reduced eGFR requires review; confirm appropriateness before contacting patient.
PHM saved action
PHM action: DIABETES_ACR_OVERDUE
status=snoozed | imported | next review=2026-07-02 | Review evidence for Urine ACR overdue; confirm appropriateness before contacting patient.
cohort_run
Cohort: Smoking / Lung Screening review cohort
completed | Chart evidence: Care element: smoking_status never smoker form | probable
phm_workflow
PHM action: SURVIVORSHIP_PLAN_DUE
status=outreach_done | imported | next review=2026-06-16 | Review evidence for Survivorship plan review due; confirm appropriateness before contacting patient.
phm_workflow
PHM action: CKD_LOW_EGFR_REVIEW
status=outreach_planned | imported | next review=2026-06-09 | Review evidence for Reduced eGFR requires review; confirm appropriateness before contacting patient.
phm_workflow
PHM action: DIABETES_ACR_OVERDUE
status=snoozed | imported | next review=2026-07-02 | Review evidence for Urine ACR overdue; confirm appropriateness before contacting patient.
clinical_flag
Survivorship plan review due
new | medium | report | Cancer history is active/imported; survivorship plan or surveillance schedule should be confirmed.
clinical_flag
Reduced eGFR requires review
accepted | medium | structured_fact | Latest eGFR 44.0 mL/min/1.73m2 requires medication and renal-risk review.
clinical_flag
Urine ACR overdue
in_review | medium | active_cohort_automation | Patient has diabetes and no recent urine ACR evidence within the synthetic monitoring window.
clinical_flag
HbA1c above target
completed | high | structured_fact | Latest HbA1c 8.3% suggests above-target glycemic control and needs clinician review.
alert
Diabetes control flag: HbA1c above target
Generated from longitudinal lab trend.
report
Laboratory
Creatinine/eGFR and urine albumin-creatinine ratio reviewed for chronic kidney disease monitoring.
report
Consult
Eye care report: glaucoma suspect reviewed. Follow-up interval documented; no urgent ocular change in this synthetic report.
report
Consult
Oncology follow-up for prostate cancer survivor. No active recurrence noted in this synthetic report. Ongoing surveillance, late effects, and primary care coordination discussed.
note
SOAP note
T2DM review. Home glucose pattern limited due to missed checks. Discussed nutrition, exercise, foot care, and medication adherence. Plan: repeat HbA1c and review cardiovascular/renal risk.
report
Laboratory
HbA1c, fasting glucose, lipid panel, creatinine/eGFR, and urine ACR reviewed for diabetes follow-up.
SOAP note
T2DM review. Home glucose pattern limited due to missed checks. Discussed nutrition, exercise, foot care, and medication adherence. Plan: repeat HbA1c and review cardiovascular/renal risk.
consult
Survivorship care reviewed for history of prostate cancer survivor. Patient asks about surveillance schedule and late effects.
SOAP note
Follow-up visit. Medication list reviewed, allergies checked, and preventive care status discussed. Patient reports stable function. Plan: update labs/vitals and arrange follow-up as clinically indicated.
Laboratory
Creatinine/eGFR and urine albumin-creatinine ratio reviewed for chronic kidney disease monitoring.
Consult
Eye care report: glaucoma suspect reviewed. Follow-up interval documented; no urgent ocular change in this synthetic report.
Consult
Oncology follow-up for prostate cancer survivor. No active recurrence noted in this synthetic report. Ongoing surveillance, late effects, and primary care coordination discussed.
Laboratory
HbA1c, fasting glucose, lipid panel, creatinine/eGFR, and urine ACR reviewed for diabetes follow-up.
Survivorship plan review due
Cancer history is active/imported; survivorship plan or surveillance schedule should be confirmed.
Reduced eGFR requires review
Latest eGFR 44.0 mL/min/1.73m2 requires medication and renal-risk review.
Urine ACR overdue
Patient has diabetes and no recent urine ACR evidence within the synthetic monitoring window.
HbA1c above target
Latest HbA1c 8.3% suggests above-target glycemic control and needs clinician review.
Hba1c
8.3 %
2026-04-22Egfr
44 mL/min/1.73m2
2026-03-24Ldl Cholesterol
4 mmol/L
2026-02-06Egfr
76 mL/min/1.73m2
2026-01-23Ldl Cholesterol
2.9 mmol/L
2025-12-10Smoking Status
Date | Type | Title | Detail |
|---|---|---|---|
cohort_run | Cohort: Smoking / Lung Screening review cohort | completed | Chart evidence: Care element: smoking_status never smoker form | probable | |
phm_workflow | PHM action: SURVIVORSHIP_PLAN_DUE | status=outreach_done | imported | next review=2026-06-16 | Review evidence for Survivorship plan review due; confirm appropriateness before contacting patient. | |
phm_workflow | PHM action: CKD_LOW_EGFR_REVIEW | status=outreach_planned | imported | next review=2026-06-09 | Review evidence for Reduced eGFR requires review; confirm appropriateness before contacting patient. | |
phm_workflow | PHM action: DIABETES_ACR_OVERDUE | status=snoozed | imported | next review=2026-07-02 | Review evidence for Urine ACR overdue; confirm appropriateness before contacting patient. | |
clinical_flag | Survivorship plan review due | new | medium | report | Cancer history is active/imported; survivorship plan or surveillance schedule should be confirmed. | |
clinical_flag | Reduced eGFR requires review | accepted | medium | structured_fact | Latest eGFR 44.0 mL/min/1.73m2 requires medication and renal-risk review. | |
clinical_flag | Urine ACR overdue | in_review | medium | active_cohort_automation | Patient has diabetes and no recent urine ACR evidence within the synthetic monitoring window. | |
clinical_flag | HbA1c above target | completed | high | structured_fact | Latest HbA1c 8.3% suggests above-target glycemic control and needs clinician review. | |
alert | Diabetes control flag: HbA1c above target | Generated from longitudinal lab trend. | |
report | Laboratory | Creatinine/eGFR and urine albumin-creatinine ratio reviewed for chronic kidney disease monitoring. | |
care_element | hba1c | ||
care_element | egfr | ||
care_element | ldl_cholesterol | ||
care_element | egfr | ||
report | Consult | Eye care report: glaucoma suspect reviewed. Follow-up interval documented; no urgent ocular change in this synthetic report. | |
care_element | ldl_cholesterol | ||
report | Consult | Oncology follow-up for prostate cancer survivor. No active recurrence noted in this synthetic report. Ongoing surveillance, late effects, and primary care coordination discussed. | |
care_element | smoking_status | never smoker | |
care_element | egfr | ||
care_element | bmi | ||
note | SOAP note | T2DM review. Home glucose pattern limited due to missed checks. Discussed nutrition, exercise, foot care, and medication adherence. Plan: repeat HbA1c and review cardiovascular/renal risk. | |
care_element | systolic_bp | ||
care_element | diastolic_bp | ||
care_element | albumin_creatinine_ratio | ||
care_element | hba1c | ||
care_element | fasting_glucose | ||
report | Laboratory | HbA1c, fasting glucose, lipid panel, creatinine/eGFR, and urine ACR reviewed for diabetes follow-up. | |
note | consult | Survivorship care reviewed for history of prostate cancer survivor. Patient asks about surveillance schedule and late effects. | |
appointment | chronic disease review | completed | |
care_element | ldl_cholesterol | ||
care_element | diastolic_bp | ||
care_element | systolic_bp | ||
care_element | egfr | ||
care_element | hba1c | ||
note | SOAP note | Follow-up visit. Medication list reviewed, allergies checked, and preventive care status discussed. Patient reports stable function. Plan: update labs/vitals and arrange follow-up as clinically indicated. | |
care_element | fasting_glucose | ||
care_element | fasting_glucose | ||
appointment | chronic disease review | completed | |
care_element | hba1c | ||
care_element | ldl_cholesterol | ||
care_element | ldl_cholesterol | ||
care_element | egfr | ||
care_element | fasting_glucose | ||
care_element | hba1c | ||
appointment | chronic disease review | completed | |
care_element | egfr | ||
care_element | hba1c |
never smoker
2025-08-05Egfr
46 mL/min/1.73m2
2025-08-02Bmi
24.3 kg/m2
2025-07-02Diastolic Bp
70 mmHg
2025-06-09Systolic Bp
134 mmHg
2025-06-09Albumin Creatinine Ratio
46.3 mg/mmol
2025-05-17Hba1c
8.2 %
2025-04-10Fasting Glucose
7.9 mmol/L
2025-03-17Ldl Cholesterol
1.4 mmol/L
2024-10-14Diastolic Bp
64 mmHg
2024-07-06Systolic Bp
117 mmHg
2024-07-06Egfr
56 mL/min/1.73m2
2024-06-13Hba1c
7.6 %
2024-05-27Fasting Glucose
10.3 mmol/L
2024-01-21Fasting Glucose
7.9 mmol/L
2023-10-27Hba1c
7.5 %
2023-09-10Ldl Cholesterol
1.8 mmol/L
2023-04-11Ldl Cholesterol
2.6 mmol/L
2022-12-28Egfr
49 mL/min/1.73m2
2022-12-22Fasting Glucose
11.6 mmol/L
2022-12-20Hba1c
8.4 %
2022-07-05Egfr
52 mL/min/1.73m2
2021-07-16Hba1c
7.8 %
2021-01-18